文献速递骨显像与常规 SPECT肿瘤 PET/CT

18F-氟化钠PET/CT作为中轴型脊柱关节炎成骨性疾病负荷的补充测量:一项前瞻性探索性研究

¹⁸F-sodium fluoride PET/CT as a complementary measure of osteoblastic disease burden in axial spondyloarthritis: a prospective exploratory study.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-10-03

结果显示SIJ SUVmax与SPARCC炎症评分(ρ=0.629)和结构评分(ρ=0.606)相关(均p<0.001),AS患者摄取中位数高于nr-axSpA和DJD,且79.3%的AS患者视觉摄取阳性(包括10/16无MRI骨髓水肿者)。

要点

  • SIJ SUVmax与MRI SPARCC炎症和结构评分均显著相关(ρ=0.629和0.606,p<0.001)。
  • AS患者SIJ SUVmax中位数14.7,高于nr-axSpA的5.5和DJD的5.7(p=0.001)。
  • 79.3%的AS患者视觉摄取阳性,包括10/16无MRI骨髓水肿者,无水肿者均无摄取增高。

核心结论

  • SIJ SUVmax可作为成骨性疾病负荷的补充定量影像生物标志物,但所有衍生阈值需外部验证。

研究设计与样本

  • 按影像学分为放射学axSpA/AS(n=29)、非放射学axSpA(n=5)和退行性关节病(DJD,n=9)。
  • MRI采用SPARCC炎症和结构评分,SIJ摄取行视觉评估和SUVmax定量,主要终点为SIJ SUVmax与SPARCC结构评分的相关性。

主要发现

  • SIJ SUVmax与SPARCC炎症评分(ρ=0.629)和结构评分(ρ=0.606)相关(均p<0.001),相互调整后关联仍存在。
  • AS、nr-axSpA和DJD的SIJ SUVmax中位数分别为14.7(11.2-22.4)、5.5(4.4-9.9)和5.7(4.0-9.2),p=0.001。
  • AS患者视觉摄取阳性23/29(79.3%),其中10/16无MRI骨髓水肿;无AS患者出现水肿而无摄取增高。
  • 外周关节和附着点摄取常见但无鉴别价值;探索性AUC为AS vs DJD 0.841,AS vs nr-axSpA 0.848。

关键数值与推荐

  • SIJ SUVmax与SPARCC炎症评分相关系数ρ=0.629(p<0.001)。
  • SIJ SUVmax与SPARCC结构评分相关系数ρ=0.606(p<0.001)。
  • AS、nr-axSpA、DJD的SIJ SUVmax中位数分别为14.7(11.2-22.4)、5.5(4.4-9.9)、5.7(4.0-9.2),p=0.001。
  • 视觉摄取阳性率:AS患者23/29(79.3%),其中无MRI骨髓水肿者10/16。
  • 探索性AUC:AS vs DJD为0.841,AS vs nr-axSpA为0.848。

临床怎么用

  • SIJ SUVmax定量有助于区分AS与DJD或nr-axSpA,但现有阈值需外部验证后方可用于临床决策。

局限性

  • 探索性研究样本量小(43例),nr-axSpA和DJD亚组例数少(分别为5例和9例)。
  • 所有衍生阈值需外部验证,AUC为探索性结果。
  • 外周关节和附着点摄取常见但无鉴别价值,视觉评估可能受主观影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine whether SIJ ¹⁸F-NaF uptake is associated with MRI-defined inflammation and structural damage and whether it provides a complementary measure of osteoblastic disease burden. METHODS: In this prospective exploratory study, 43 adults with chronic low back pain underwent pelvic radiography, sacroiliac joint (SIJ)-MRI, and whole-body ¹⁸F-NaF PET/CT and were classified as having radiographic axial spondyloarthritis or ankylosing spondylitis (AS; n = 29), non-radiographic axial spondyloarthritis (nr-axSpA; n = 5), or degenerative joint disease (DJD; n = 9). MRI was evaluated using SPARCC inflammation and structural scores. SIJ uptake was assessed visually and quantified using SUVmax. The primary endpoint was the correlation between SIJ SUVmax and the SPARCC structural score. RESULTS: SIJ SUVmax correlated with the SPARCC inflammation (ρ = 0.629) and structural (ρ = 0.606) scores (both p < 0.001) on SIJ-MRI; both associations persisted after mutual adjustment. Median SIJ SUVmax differed across AS, nr-axSpA, and DJD (14.7 [11.2-22.4], 5.5 [4.4-9.9], and 5.7 [4.0-9.2], respectively; p = 0.001). Visually positive uptake occurred in 23/29 (79.3%) patients with AS, including 10/16 without MRI-defined bone marrow edema; no patient with AS had edema without increased uptake. Peripheral joint and entheseal uptake were frequent but non-discriminatory. Exploratory AUCs were 0.841 for AS versus DJD and 0.848 for AS versus nr-axSpA. CONCLUSION: SIJ ¹⁸F-NaF uptake was associated with both MRI-defined inflammation and structural burden in patients with AS, including those without active inflammation on MRI. SIJ SUVmax warrants evaluation as a complementary quantitative imaging biomarker of osteoblastic disease burden, but all derived thresholds require external validation.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Chen HY, Chiu YL, Lyu SY, et al. ¹⁸F-sodium fluoride PET/CT as a complementary measure of osteoblastic disease burden in axial spondyloarthritis: a prospective exploratory study. Eur J Nucl Med Mol Imaging. 2026. PMID: 42827149. doi:10.1007/s00259-026-08190-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。